Internal Medicine, Hematology & Oncology · Madison, WI
NPI
1699161901
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
Uw Hospital and Clinics, 600 Highland Ave
Madison, WI, 53792
Phone (608) 263-5660
Groups this clinician bills Medicare through
Medicare paid, 2024
$954K
61,296 services
Medicare patients, 2024
405
Average age 74
Drug cost, 2024
$2.3M
811 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luke D Zurbriggen was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 12,750 times for 13 patients. In total Luke D Zurbriggen billed 61,296 services in 126 codes, and Medicare paid $954K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 12,750 | 13 | $0.28 | $3,555 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,348 | 11 | $36.46 | $49K |
| 36415 Venipuncture Blood Collection | Office | 530 | 121 | $8.62 | $4,568 |
| 99214 Office E&M - Established | Office | 266 | 155 | $87.22 | $23K |
| 96401 Chemotherapy Administration | Office | 201 | 18 | $52.91 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 135 | 97 | $12.08 | $1,630 |
| 96413 Chemotherapy Administration | Office | 82 | 43 | $95.83 | $7,858 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 78 | 12 | $139.02 | $11K |
| 96372 Injection Administration | Office | 71 | 31 | $10.72 | $761 |
| 96365 Intravenous Infusion, Hydration | Office | 67 | 43 | $43.26 | $2,898 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 63 | 12 | $3.77 | $237 |
| 99215 Office E&M - Established | Office | 59 | 43 | $117.92 | $6,957 |
| 85025 Blood Count | Office | 53 | 20 | $7.61 | $403 |
| 96402 Chemotherapy Administration | Office | 48 | 23 | $26.34 | $1,264 |
| 99205 Office E&M - New | Office | 42 | 42 | $158.97 | $6,677 |
By year: 2022 $744K for 53,731 services; 2023 $1.0M for 85,566 services; 2024 $954K for 61,296 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 530 | 121 | $8.62 | $4,568 |
| 85025 Blood Count | 53 | 20 | $7.61 | $403 |
Medicare prescription drug claims, 2024
In 2024, the drug Luke D Zurbriggen prescribed most often to Medicare patients was Acyclovir, with 140 prescriptions and refills. In total Luke D Zurbriggen wrote 811 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 140 | 186 | 27 | $1,507 |
| Hydroxyurea Generic | 61 | 126 | 16 | $1,583 |
| Prednisone Generic | 58 | 62 | 16 | $415 |
| Ondansetron Hcl Generic | 46 | 48 | 23 | $536 |
| Eliquis Apixaban | 35 | 56 | Under 11 | $30K |
| Jakafi Ruxolitinib Phosphate | 32 | 32 | Under 11 | $533K |
| Dexamethasone Generic | 30 | 36 | 16 | $399 |
| Mycophenolate Mofetil Generic | 28 | 36 | Under 11 | $18K |
| Levofloxacin Generic | 26 | 26 | Under 11 | $118 |
| Prochlorperazine Maleate Generic | 25 | 25 | 11 | $326 |
| Lumakras Sotorasib | 24 | 24 | Under 11 | $514K |
| Fluconazole Generic | 19 | 25 | Under 11 | $838 |
| Lenalidomide Generic | 18 | 18 | Under 11 | $248K |
| Folic Acid Generic | 18 | 18 | Under 11 | $90.48 |
| Abiraterone Acetate Generic | 17 | 17 | Under 11 | $22K |
Brand drugs: 165 claims; generic drugs: 646 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Luke D Zurbriggen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.